-
View DetailCEFTAZIDIME JUNO ceftazidime (as pentahydrate) 2g powder for injection vial
Availability: Reduction in supply until supply is exhausted Deletion from market: 30 Sep 2025 -
View Detail
UROCARB bethanechol chloride 10 mg
Availability: Reduction in supply until supply is exhausted Deletion from market: 16 Jan 2026 -
View Detail
FORTEO teriparatide (rbe) 250 microgram
Availability: Reduction in supply until supply is exhausted Deletion from market: 30 Jun 2025 -
View Detail
DEXMEDETOMIDINE SANDOZ dexmedetomidine (as hydrochloride) 200 microgram/2 mL
Availability: Reduction in supply until supply is exhausted Deletion from market: 06 Jun 2025 -
View Detail
Pfizer (Australia) SODIUM CHLORIDE 0.9% (900mg/100mL
Availability: Reduction in supply until supply is exhausted Deletion from market: 01 Sep 2025 -
-
Ropivacaine-AFT 0.2% ropivacaine hydrochloride 200 mg/100 mL
Availability: Unavailable Deletion from market: 13 Sep 2023 -
DBL Bortezomib bortezomib 1.0 mg
Availability: Reduction in supply until supply is exhausted Deletion from market: 01 Oct 2024 -
View Detail
TWYNSTA 40/5 telmisartan 40 mg
Availability: Reduction in supply until supply is exhausted Deletion from market: 31 Dec 2025 -
View Detail
TWYNSTA 80/10 telmisartan 80 mg
Availability: Reduction in supply until supply is exhausted Deletion from market: 31 Dec 2025 -
View Detail
PRITOR/AMLODIPINE 40 mg/5 mg
Availability: Reduction in supply until supply is exhausted Deletion from market: 31 Dec 2025 -
View Detail
PRITOR/AMLODIPINE 40 mg/10 mg
Availability: Reduction in supply until supply is exhausted Deletion from market: 31 Dec 2025
